Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

Trial ID or NCT#

NCT01932060

Status

not recruiting iconNOT RECRUITING

Purpose

Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.

Official Title

Effects of Different Oxytocin Infusions on Blood Loss and Postpartum Hemoglobin Values in Patients Undergoing Elective Cesarean Delivery

Eligibility Criteria

Ages Eligible for Study: 18 Years to 40 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Healthy pregnant patients with uncomplicated pregnancies: - ASA (American Association of Anesthesiologists) class 1 or 2 patients. - Singleton pregnancies.
Exclusion Criteria:
  1. - ASA class 3 or 4 patients. - Known drug allergy to intravenous oxytocin. - Significant medical or obstetric disease. - Known uterine abnormality. - Known placental abnormality.
View All Criteria
Show Less

Investigator(s)

Alex Butwick
Alex Butwick
Anesthesiologist
Professor of Anesthesiology, Perioperative and Pain Medicine (OB)

Contact us to find out if this trial is right for you.

Contact

Alexander J Butwick, F.R.C.A
650-736-8513

View on ClinicalTrials.gov